Monopar Therapeutics Inc. (MNPR) Total assets 2016–2025
Monopar Therapeutics Inc. (MNPR) total assets at each fiscal year-end, per SEC filings.
$140.7MFY2025 · since FY2016: $2.9M → $140.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $140.7M | +133.4% |
| FY2024 | $60.3M | — |
| FY2019 | $13.4M | +82.5% |
| FY2018 | $7.3M | -26.3% |
| FY2017 | $9.9M | +243.0% |
| FY2016 | $2.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MNPR financial trends
MNPR RevenueMNPR Net incomeMNPR Net marginMNPR Gross profitMNPR Gross marginMNPR Operating incomeMNPR Operating marginMNPR Operating cash flowMNPR Free cash flowMNPR Capital expendituresMNPR Return on equityMNPR Stock buybacksMNPR Dividends paidMNPR Total liabilitiesMNPR Shareholders’ equityMNPR overview →